Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Tuesday, December 8, 2009, 11:46AM ET - U.S. Markets close in 4 hours and 14 minutes. Dow Down 0.62% Nasdaq Down 0.22%
SenoRx, Inc. (SENO)At 11:22AM ET: 5.20  Up 0.10 (1.96%)  
MORE ON SENO
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
SenoRx, Inc.
3 Morgan
Irvine, CA 92618
United States - Map
Phone: 949-362-4800
Fax: 949-362-3519
Web Site: http://www.senorx.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Instruments & Supplies
Full Time Employees:155

BUSINESS SUMMARY 
SenoRx, Inc., a medical device company, develops, manufactures, and sells devices for the diagnosis and treatment of breast cancer. The company offers diagnostic products, including breast biopsy systems, and location and lymph node gamma ray detection devices; and marking products comprising tissue markers, which identify the biopsy site for future diagnostic and surgical reference. It also provides excising products, which is a tissue cutting devices designed to facilitate the contoured removal of lesions and facilitate the use of balloons in radiation therapy; and treatment products, including radiation balloons for localized partial breast radiation therapy. The company’s breast biopsy systems include SenoRx Breast Biopsy Console, EnCor, EnCor 360(3), VisiLoc, SenoSonix, and SenoSonix Handcarry; tissue markers and location devices comprise Gel Mark, Gel Mark Ultra, Gel Mark UltraCor, SenoMark, Gel Mark UltraCor MRI, Tissue Marker Line Extension, Starch Mark, and Loc Wire Replacement; and gamma ray detection devices consist of Gamma Finder. Its excision and reconstruction products include SenoPulse RF Generator and Single Step; and radiation therapy products comprise Contura MLB, Contura Shape Select MLB, and CED Device. SenoRx, Inc. markets its products through direct sales force and distributors in the United States and internationally. The company was formerly known as BiopSolation Medical, Inc. and changed its name to SenoRx, Inc. SenoRx, Inc. was founded in 1998 and is headquartered in Irvine, California.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on SenoRx, Inc.


    CORPORATE GOVERNANCE 
    SenoRx, Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Dec-09 is better than 46% of CGQ Universe companies and 29% of Health Care Equipment & Services companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. Lloyd H. Malchow , 55
    Chairman and Chief Exec. Officer
    $ 385.00K $ 0
    Mr. John T. Buhler , 48
    Pres and Chief Operating Officer
    $ 177.00K $ 0
    Mr. Paul Lubock , 53
    Co-Founder, Chief Technical Officer and Sr. VP
    $ 266.00K $ 0
    Mr. Kevin J. Cousins , 54
    Chief Financial Officer, Principal Accounting Officer and VP of Fin.
    $ 254.00K $ 0
    Mr. William F. Gearhart , 61
    VP of Global Marketing & Corp. Devel.
    $ 269.00K $ 0
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis